JOHNSON & JOHNSON

JNJ
Exchange NYQ, Currency in USD
Loading price...

Overview

Previous Close255.82
Open256.01
Ask257.31
Bid256.00
Day's Range253.29 - 258.47
52 Week Range166.64 - 274.90
PE Ratio(TTM)29.77
Market Cap617.78B
Volume4.55M
Avg. Volume8.27M
12 Months Earnings21.04B
12 Months Revenue97.93B

Performance

ABSCAGR
YTD1 Month3 Months1 Year2 Years5 Years10 Years
No results to display

Profit/Loss

PARTICULARSTTM20252025202420232022
Operating Revenue97.93B94.19B90.63B88.82B85.16B79.99B
Cost of Revenue31.43B30.26B29.08B27.47B26.55B24.60B
Gross Profit66.50B63.94B61.55B61.35B58.61B55.39B
Operating Expenses40.24B38.34B39.22B40.10B36.60B34.38B
Profit after Tax (Net Income)21.04B26.80B22.66B14.07B35.15B17.94B

Company Profile

Sector: Healthcare
Industry: Drug Manufacturers - General
HQ Location: New Brunswick, United States
Website: https://www.jnj.com
CEO & Chairman: Mr. Joaquin Duato
Employees: 138,200
About Company:
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.